Simulating an Immune Response with a Combined Agent-Based Model of a Triple-Negative Breast Cancer Tumor and Vascular Network

被引:2
|
作者
Ventoso, Michael [1 ]
Norton, Kerri-Ann [1 ]
机构
[1] Bard Coll, Div Sci Math & Comp, Annandale On Hudson, NY 12504 USA
关键词
cancer; modeling; angiogenesis; T-cell; lymphocyte; MIGRATION; SURVIVAL;
D O I
10.1109/BIBM49941.2020.9313463
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytotoxic T-cells (CTLs) are one mechanism the immune system employs to eliminate cancer cells. In this study, we expand upon a previous 3-dimensional agent-based model of triple-negative breast cancer to include an immuno-therapy in the form of a CTL insertion into the tumor. The model consists of a triple-negative breast tumor, comprised of progenitor cells, cancer stem cells, tumor-associated macrophages, as well as an expanding vascular network. We investigate the treatment effects of inserting different numbers of CTLs into the tumor microenvironment, and their overall effect on tumor size in the short and longer terms. The results show that while CTLs decrease the size of the tumor they are ineffective at completely eliminating it, leading to continued tumor proliferation in the aftermath.
引用
收藏
页码:1303 / 1310
页数:8
相关论文
共 50 条
  • [11] Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
    Huang, Pengfei
    Zhou, Xinyue
    Zheng, Minying
    Yu, Yongjun
    Jin, Gongsheng
    Zhang, Shiwu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [12] The role of the immune system in triple-negative breast cancer
    Cvetka, Grasic Kuhar
    ONKOLOGIJA, 2020, 24 (01) : 32 - 38
  • [13] Remarkable response to combined immunochemotherapy in patients with metastatic triple-negative breast cancer
    Philipovskiy, Alexander
    Chambers, Karinn
    Konstantinidis, Ioannis
    McCallum, Richard
    Corral, Javier
    Gaur, Sumit
    IMMUNOTHERAPY, 2020, 12 (18) : 1293 - 1302
  • [14] REMARKABLE RESPONSE TO COMBINED IMMUNOCHEMOTHERAPY IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER
    Ghafouri, S.
    Chambers, K.
    Konstantinidis, I.
    McCallum, R.
    Corral, J.
    Gaur, S.
    Philipovskiy, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 554 - 555
  • [15] Mathematical Model of Triple-Negative Breast Cancer in Response to Combination Chemotherapies
    Davenport, Angelica A. A.
    Lu, Yun
    Gallegos, Carlos A. A.
    Massicano, Adriana V. F.
    Heinzman, Katherine A. A.
    Song, Patrick N. N.
    Sorace, Anna G. G.
    Cogan, N. G.
    BULLETIN OF MATHEMATICAL BIOLOGY, 2023, 85 (01)
  • [16] Mathematical Model of Triple-Negative Breast Cancer in Response to Combination Chemotherapies
    Angelica A. Davenport
    Yun Lu
    Carlos A. Gallegos
    Adriana V. F. Massicano
    Katherine A. Heinzman
    Patrick N. Song
    Anna G. Sorace
    N. G. Cogan
    Bulletin of Mathematical Biology, 2023, 85
  • [17] A novel risk model based on immune response predicts clinical outcomes and characterizes immunophenotypes in triple-negative breast cancer
    Lu, Xunxi
    Gou, Zongchao
    Yu, Luoting
    Bu, Hong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (08): : 3913 - +
  • [18] An In Vitro Model of Triple-Negative Breast Cancer
    Russo, J.
    Su, Y.
    HUMAN CELL TRANSFORMATION: ADVANCES IN CELL MODELS FOR THE STUDY OF CANCER AND AGING, 2019, 1164 : 35 - 46
  • [19] Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer
    Tung, Nadine M.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 969 - +
  • [20] Tumor microenvironment and immunotherapy for triple-negative breast cancer
    Guo, Zijie
    Zhu, Ziyu
    Lin, Xixi
    Wang, Shenkangle
    Wen, Yihong
    Wang, Linbo
    Zhi, Lili
    Zhou, Jichun
    BIOMARKER RESEARCH, 2024, 12 (01)